Biocenter Finland
Biocenter Finland is a national non-profit research infrastructure network coordinating 17 life science technology platforms across six Finnish universities, providing open-access services to 3,000+ research groups annually in academia, industry, and international users.
- Company typePrivate
- Founded2007
- HeadquartersHelsinki, Finland
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Biocenter Finland does
Biocenter Finland is a national non-profit research infrastructure network established in 2007, jointly operated by five biocenters across six Finnish universities — the University of Eastern Finland, the University of Helsinki, the University of Oulu, Tampere University, the University of Turku, and Åbo Akademi University. The organization coordinates 17 technology platform services covering the full spectrum of life sciences: biobank technologies, bioinformatics, biological imaging, drug discovery and chemical biology, electrophysiology, flow cytometry, genome-wide methods, metabolomics, mouse and plant model organisms, protein-proteome analysis, real-time imaging, single-cell omics, stem cells and genome editing, structural biology, and viral gene transfer and cell therapy. These platforms collectively serve over 3,000 research groups annually across the Finnish academic community, life science industry, and international users, with documented integration into ESFRI European research infrastructure networks including BBMRI, EATRIS, ELIXIR, EU-OPENSCREEN, Euro-BioImaging, FINStruct, INFRAFRONTIER, Instruct-ERIC, and EMBL. The majority of Finland's national Centres of Excellence, Academy Professors, ERC grantees, and Flagships in Life Sciences rely on Biocenter Finland services.
Biocenter Finland operates on a publicly-funded, open-access model. Personnel costs are financed by host universities, while platform investment is coordinated through competitive sources, principally the Research Council of Finland's FIRI (Roadmap for Finnish Research Infrastructures) instrument. In 2025, Biocenter Finland was selected for the FIRI 2025–2028 Roadmap with excellent reviews and was awarded Lighthouse Status — the first time this recognition has been granted to any Finnish research infrastructure. Pricing is not publicly disclosed; services are provided on an open-access basis. Distribution occurs directly through platform nodes at the six host universities and through ESFRI-affiliated international access channels. Marketing and engagement are driven by an event-based model including the BioCity Symposium, bioinformatics webinars, proteomics symposia, electrophysiology training courses, Biocenter Finland Day, and high-content imaging symposia. Leadership is in transition: Katja Kivinen has been appointed as the new Director effective April 1, 2026, succeeding Olli Silvennoinen.
Biocenter Finland firmographics
Firmographics- Name
- Biocenter Finland
- Legal name
- Biocenter Finland
- Website
- https://biocenter.fi
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Biocenter Finland is a national non-profit research infrastructure network coordinating 17 life science technology platforms across six Finnish universities, providing open-access services to 3,000+ research groups annually in academia, industry, and international users.
- Ownership category
- akta.pro rank
Biocenter Finland industry classification
Industry- Product category
- Life Science Research Infrastructure
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industries
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Proteomics & Biomarker Analytical Testing (HLAGADAG), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Microbiome & Metagenomics Services (HLAGANAH), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Translational Medicine & Biomarkers (HLAIALAF)
Keywords
Where Biocenter Finland is headquartered
LocationHeadquarters
- HQ city
- Helsinki
- HQ country
- Finland
- HQ region
- Europe
Offices5 records
Markets served
Biocenter Finland business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Research Infrastructure Funding: Biocenter Finland is a non-profit national research infrastructure funded through competitive sources, host university contributions, and government funding. Personnel costs are financed by host universities. The organization was selected for the Research Council of Finland's Roadmap for Finnish Research Infrastructures (FIRI) 2025-2028 and received Lighthouse Status.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Biocenter Finland product offering
Product offeringCore offering
Biocenter Finland is a national life science research infrastructure network that coordinates 17 technology platforms distributed across six Finnish universities, providing open-access services in genomics, proteomics, single-cell omics, imaging, structural biology, electrophysiology, bioinformatics, metabolomics, biobanking, mouse and non-mammalian model organisms, plant phenotyping, stem cells and genome editing, drug discovery and chemical biology, and viral gene transfer. Services are delivered to academic researchers, industry, and international users, with personnel costs financed by host universities and infrastructure investments coordinated through competitive sources including the Research Council of Finland FIRI Roadmap.
Product overview
Biocenter Finland is a national research infrastructure network established in 2007 that develops and coordinates life science research infrastructures across Finnish universities. The organization operates as a platform-of-platforms architecture, consisting of 17 interconnected technology platform services spanning the full spectrum of life sciences research. These include Biobank Technologies, Bioinformatics, Biological Imaging, Drug Discovery and Chemical Biology (including FIMM-HTB compound libraries), Finnish Electrophysiology Platform (FinE), Flow Cytometry, Genome-wide Methods, Metabolomics, FinGMice (mouse models), National Plant Phenotyping (NaPPI), Non-mammalian Model Organisms, Protein-Proteome Network (PPN), Real-time Imaging, Single-Cell Omics, Stem Cells and Genome Editing, Structural Biology (FINStruct), and Viral Gene Transfer and Cell Therapy platforms. The platforms are distributed across five biocenters at six Finnish universities (University of Helsinki, University of Oulu, University of Eastern Finland, Tampere University, University of Turku, and Åbo Akademi University), providing open-access cutting-edge technologies to academia, industry, and international users. The infrastructure enables research from genomics and single-cell omics to advanced imaging, structural biology, and data-driven science, serving over 3,000 research groups annually.
Differentiator
Problem solved
Functional benefit
Products and services
- Biobank Technologies Platform Provides biobanking technologies and infrastructure services for storing, managing, and analyzing biological samples and associated data for research purposes across Finnish universities and the research community.
- Bioinformatics Platform Offers computational biology services, data analysis tools, and bioinformatics expertise for omics data processing, interpretation, and integration across genomics, transcriptomics, proteomics, and metabolomics for academic and industry users.
- Biological Imaging Platform Provides advanced microscopy and imaging services including high-content imaging, confocal microscopy, and specialized imaging techniques for life science research across Finnish universities.
- Drug Discovery and Chemical Biology (DDCB) Platform Supports drug discovery research through compound library access, high-throughput screening services, and chemical biology expertise including FIMM-HTB unit for compound library screening for academic researchers and industry users.
- Finnish Electrophysiology Platform (FinE) Provides electrophysiology services including recordings in cell cultures and organoids, disease modeling, neuronal, retinal, and cardiac physiology, organ-on-chip technologies, and microelectrode array (MEA) technologies for Finnish researchers.
- Flow Cytometry Platform Offers cell sorting and analysis services using flow cytometry technology for characterizing and isolating cell populations for academic and industry research.
- Genome-wide Methods Platform Provides genomics and transcriptomics services including whole genome, whole exome, targeted panel, cell-free DNA, transcriptome, metagenome, methylation sequencing, Sanger sequencing, and genotyping for research users.
- Metabolomics Platform Offers mass spectrometry and NMR-based metabolomics services for analyzing small molecules including lipids and hydrophilic compounds from animal, plant, and microbial sources, with targeted and untargeted approaches.
- FinGMice (Finnish Genetically Modified Mice) Platform National technology platform for generation, analysis, and archiving of rodent models including CRISPR/Cas9 design, transgenic services, phenotyping, cryopreservation, and behavioral testing services for Finnish researchers.
- National Plant Phenotyping Infrastructure (NaPPI) Provides high-throughput plant phenotyping services with automated imaging for monitoring plant growth, morphology, physiology, leaf temperature, and photosynthesis using RGB, thermal, and chlorophyll fluorescence imaging.
- Non-mammalian Model Organisms Platform Offers services for fish and fly models including Drosophila and zebrafish husbandry, colony management, genetic manipulation (CRISPR/Cas), phenotyping, and infection models for the research community.
- Protein-Proteome Network (PPN) Platform Provides proteomics services ranging from MS and non-MS-based proteomics to protein production and biophysical characterization, including mass spectrometry, protein identification, quantitative proteomics, and PTM analysis for academic and industry users.
- Real-time Imaging (RTI) Platform Specialized radio nuclear imaging platform with SPECT/CT and Radiopharmaceutical Chemistry (RadChem) nodes for whole nuclear imaging projects from design to execution, including in vivo small animal imaging and custom PET/SPECT tracer synthesis.
- Single-Cell Omics Platform Provides single-cell and spatial transcriptomics services including single-cell genomics (Tapestri), transcriptomics (Chromium, BD Rhapsody), epigenomics, proteomics (Helios mass cytometry), and spatial omics (Visium, GeoMX DSP, Hyperion) for academic and industry users.
- Stem Cells and Genome Editing Platform Offers iPS cell line production, stem cell differentiation, genome editing services (CRISPR/Cas9), arrayed CRISPR screening, neural iPSC services, and cell line editing for disease modeling and drug discovery applications.
- Structural Biology (FINStruct) Platform National coordinated network providing integrated structural biology services including cryo-electron microscopy, native mass spectrometry, X-ray crystallography, protein crystallography, and biomolecular complex purification for academic and industrial users, with IceBear data management for crystallography scoring.
- Viral Gene Transfer and Cell Therapy (VGTCT) Platform Provides viral vector production and gene transfer services including adenovirus, lentivirus, AAV vectors, CRISPR vectors, and cell therapy support with GMP-trained personnel for clinical applications in research and translational settings.
Quantifiable outcome
- Serves over 3,000 research groups annually
- +2 more outcomes
Companies that use Biocenter Finland
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Biocenter Finland technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration17 records
AI capability13 records
Feature3 records
Biocenter Finland partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core and minor.
- BBMRI (European Research Infrastructure for Biobanking and Biomolecular Resources)coreBiocenter Finland maintains close interaction with the Finnish node of BBMRI as part of its European research infrastructure collaboration
- EATRIS (European Research Infrastructure for Translational Medicine)coreBiocenter Finland collaborates with EATRIS Finnish node for translational medicine research infrastructure
- ELIXIR (European Life Science Infrastructure)coreBiocenter Finland collaborates with ELIXIR Finnish node as part of European-wide bioinformatics and data infrastructure
- EU-OPENSCREEN (European Research Infrastructure for Chemical Biology)coreBiocenter Finland maintains interaction with EU-OPENSCREEN for chemical biology research infrastructure services
- Euro-BioImaging (European Research Infrastructure for Biological Imaging)coreBiocenter Finland collaborates with Euro-BioImaging for advanced biological imaging services and access
- FINStruct (Structural Biology Finland)coreFINStruct is a national coordinated multi-institution network providing integrated structural biology services. Biocenter Finland coordinates with FINStruct for cryo-EM, X-ray crystallography, native mass spectrometry, and other structural biology services
- INFRAFRONTIER (European Research Infrastructure for Phenotyping and Archiving of Model Mammalian Genomes)coreBiocenter Finland coordinates with INFRAFRONTIER for mouse model generation, phenotyping, and archiving services through FinGMice platform
- Instruct-ERIC (European Research Infrastructure for Structural Biology)coreBiocenter Finland coordinates with Instruct-ERIC Centre Finland at Universities of Helsinki, Oulu, and Eastern Finland for access to structural biology services
- EMBL (European Molecular Biology Laboratory)coreFinland is a member of EMBL and the European Molecular Biology Conference (EMBC). Institute of Molecular Medicine Finland (FIMM) is part of the Nordic EMBL Partnership for Molecular Medicine
- DeepScan DiagnosticsminorFormer affiliation of new Director Katja Kivinen before joining Biocenter Finland as Chief Scientific Officer
- University of Eastern FinlandcoreHost university hosting Biocenter Kuopio with support endorsed for 2025-2028 based on action plan 'From Data to Innovations and Beyond'
- University of HelsinkicoreHost university hosting Helsinki Institute of Life Science HiLIFE. Coordinating university for Biocenter Finland with Director employment. All host universities have prioritized life sciences in their current strategies
- University of OulucoreHost university hosting Biocenter Oulu with support endorsed for 2025-2028 based on action plan 'From Data to Innovations and Beyond'
- Tampere UniversitycoreHost university hosting Faculty of Medicine and Health Technology with support endorsed for 2025-2028 based on action plan 'From Data to Innovations and Beyond'
- University of TurkucoreHost university hosting BioCity Turku with support endorsed for 2025-2028 based on action plan 'From Data to Innovations and Beyond'
- Åbo Akademi UniversitycoreHost university partnering with University of Turku through BioCity Turku with support endorsed for 2025-2028 based on action plan 'From Data to Innovations and Beyond'
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
Biocenter Finland competitors and assessment
Company assessmentDirect peers
- INFRAFRONTIER: European research infrastructure for model organism generation, phenotyping, and archiving, with Biocenter Finland's FinGMice platform serving as the Finnish node. Directly comparable in providing mouse model and phenotyping services.
- SciLifeLab: Sweden's national life science research infrastructure network, distributed across multiple universities and offering a comparable platform-of-platforms model including genomics, proteomics, imaging, and bioinformatics. Directly comparable in mission, structure, and funding mechanism as a Nordic national research infrastructure.
- Euro-BioImaging: Pan-European research infrastructure consortium for biological imaging, of which Biocenter Finland hosts the Finnish node. Operates a comparable open-access distributed imaging service model across multiple countries.
- EATRIS: European infrastructure for translational medicine, collaborating with Biocenter Finland's Finnish node. Comparable in providing translational research infrastructure services and supporting industry-academia collaboration in life sciences.
- Instruct-ERIC: European research infrastructure for structural biology, with Biocenter Finland's FINStruct serving as the Finnish distributed partner. Comparable in providing integrated structural biology services to academic and industrial users.
- ELIXIR: European life science infrastructure for biological data, with Biocenter Finland representing the Finnish node. Comparable in providing bioinformatics and data services across member states under a distributed coordination model.
- BBMRI-ERIC: European research infrastructure for biobanking and biomolecular resources, with Biocenter Finland's Biobank Technologies platform serving as the Finnish node. Directly comparable in providing biobanking services and research infrastructure coordination.
- EU-OPENSCREEN: European research infrastructure for chemical biology and early drug discovery, with Biocenter Finland's DDCB platform as a node. Comparable in providing high-throughput screening, compound libraries, and chemical biology services.
Regional players
- Danish National Life Science Infrastructure (Copenhagen Bio Science Park / DANDRITE): Denmark's national research infrastructure for neuroscience and molecular life sciences, comparable in serving as a Nordic national coordination entity for advanced life science technologies and platforms.
Broad incumbents
- EMBL (European Molecular Biology Laboratory): Intergovernmental research organization in molecular life sciences; Finland is a member state and Biocenter Finland's FIMM is part of the Nordic EMBL Partnership. Broader incumbent offering research, services, and training across the molecular life sciences spectrum.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Biocenter Finland social profiles
Digital presenceBiocenter Finland compliance and trust
Trust signalCompliance2 records
Biocenter Finland financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biocenter Finland leadership team
Management profileNumber of profiles
Profiles11 records
Biocenter Finland funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biocenter Finland M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biocenter Finland
What does Biocenter Finland do?
Biocenter Finland is a national life science research infrastructure network that coordinates 17 technology platforms distributed across six Finnish universities, providing open-access services in genomics, proteomics, single-cell omics, imaging, structural biology, electrophysiology, bioinformatics, metabolomics, biobanking, mouse and non-mammalian model organisms, plant phenotyping, stem cells and genome editing, drug discovery and chemical biology, and viral gene transfer. Services are delivered to academic researchers, industry, and international users, with personnel costs financed by host universities and infrastructure investments coordinated through competitive sources including the Research Council of Finland FIRI Roadmap.
Is Biocenter Finland a public or private company?
Biocenter Finland is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Biocenter Finland founded?
Biocenter Finland was founded in 2007. It employs 1 to 10 people.
Where is Biocenter Finland based?
Biocenter Finland is headquartered in Helsinki, Finland, in the Europe region.
How does Biocenter Finland make money?
One revenue line is on record: research Infrastructure Funding.
Who are Biocenter Finland's main competitors?
Direct peers on record are INFRAFRONTIER, SciLifeLab, Euro-BioImaging, EATRIS, Instruct-ERIC, ELIXIR, BBMRI-ERIC and EU-OPENSCREEN. Danish National Life Science Infrastructure (Copenhagen Bio Science Park / DANDRITE) is listed as a regional player. EMBL (European Molecular Biology Laboratory) is listed as a broad incumbent.
Does Biocenter Finland have an API?
No public API is recorded for Biocenter Finland.
What industry is Biocenter Finland in?
Biocenter Finland's product category is Life Science Research Infrastructure. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 541714 and its SIC code is 8731.